Dyadic International (NASDAQ: DYAI) is one of today’s top-performing stocks.
If you want to invest in Dyadic International stock, or if you simply want to know more about the company and why it is surging in value, this article should help you out. Read on to find out key information like what the company is, what it does, and what our DYAI stock price forecast is for the next year.
For those of you who want to buy shares in Dyadic immediately, check out the section directly below; our analysts have listed the two best places to buy DYAI stock online.
How & where to buy Dyadic International shares today
To buy Dyadic shares, click on one of the links below to sign up to a reliable, low-free stockbroker. Then, add funds to your account and purchase the number of shares you want.
Here are the two best platforms to buy, sell and trade Dyadic stock right now:
eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.
Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.
What is Dyadic International?
Founded in 1979 and headquartered in Jupiter, Florida, it is a biotechnology platform company that develops, produces, and sells enzymes and other proteins in the United States.
Its main range of products are human and animal vaccines and drugs, such as virus-like particles and antigens, monoclonal antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. Yep, certainly a mouthful if you don’t have a PhD.
The DYAI share price has surged on good news. Specifically, Dyadic has signed a COVID-19 vaccine technology transfer and licensing agreement with Rubic Consortium. This is a South African-based company that aims to develop a solution for the discovery, development, evaluation, and manufacture of high-quality vaccines for distribution primarily in the African markets.
Should I buy Dyadic stock today?
If you have done due diligence and have determined that this is a stock that is set to grow, investing now could be a smart move.
However, investing always carries risk, and this is especially true for biotech companies. Make sure to be extra cautious.
Dyadic International price target 2021
Our DYAI price forecast is as follows: a 12-month high of $10, with a median of $8 and a low of $6.